Polar Capital LLP increased its stake in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 37.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 614,413 shares of the company’s stock after acquiring an additional 167,328 shares during the period. Polar Capital LLP owned 1.00% of Medidata Solutions worth $41,424,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of MDSO. Benjamin F. Edwards & Company Inc. grew its holdings in Medidata Solutions by 127.2% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 945 shares of the company’s stock valued at $64,000 after buying an additional 529 shares during the last quarter. Oppenheimer Asset Management Inc. acquired a new stake in Medidata Solutions in the 4th quarter valued at approximately $90,000. Advisor Group Inc. grew its holdings in Medidata Solutions by 27.1% in the 4th quarter. Advisor Group Inc. now owns 2,553 shares of the company’s stock valued at $173,000 after buying an additional 545 shares during the last quarter. Whittier Trust Co. of Nevada Inc. grew its holdings in Medidata Solutions by 1,068.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 2,558 shares of the company’s stock valued at $172,000 after buying an additional 2,339 shares during the last quarter. Finally, Stephens Inc. AR grew its holdings in Medidata Solutions by 8.7% in the 4th quarter. Stephens Inc. AR now owns 2,722 shares of the company’s stock valued at $184,000 after buying an additional 218 shares during the last quarter.
Get Medidata Solutions alerts:
Shares of NASDAQ:MDSO traded up $0.56 during trading on Wednesday, hitting $75.60. 593 shares of the stock were exchanged, compared to its average volume of 492,759. Medidata Solutions Inc has a 1-year low of $60.10 and a 1-year high of $88.87. The firm has a market capitalization of $4.42 billion, a PE ratio of 78.65, a PEG ratio of 5.12 and a beta of 1.32. The company has a current ratio of 2.71, a quick ratio of 2.52 and a debt-to-equity ratio of 0.14.
Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Tuesday, February 12th. The company reported $0.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.08. The business had revenue of $167.19 million during the quarter, compared to the consensus estimate of $168.08 million. Medidata Solutions had a return on equity of 10.03% and a net margin of 8.17%. Medidata Solutions’s revenue was up 18.1% on a year-over-year basis. During the same quarter last year, the company earned $0.41 EPS. On average, sell-side analysts predict that Medidata Solutions Inc will post 0.8 EPS for the current year.
Several analysts have recently weighed in on the company. BidaskClub lowered Medidata Solutions from a “buy” rating to a “hold” rating in a report on Monday, January 7th. Zacks Investment Research lowered Medidata Solutions from a “hold” rating to a “sell” rating in a report on Wednesday, December 19th. Finally, TheStreet lowered Medidata Solutions from a “b” rating to a “c+” rating in a report on Thursday, December 20th. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the company’s stock. Medidata Solutions has an average rating of “Hold” and an average target price of $83.64.
In related news, Director Robert Taylor sold 2,120 shares of the firm’s stock in a transaction that occurred on Monday, January 7th. The stock was sold at an average price of $64.70, for a total transaction of $137,164.00. Following the completion of the transaction, the director now owns 41,916 shares in the company, valued at approximately $2,711,965.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael Pray sold 15,000 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $76.50, for a total value of $1,147,500.00. Following the transaction, the executive vice president now owns 77,134 shares of the company’s stock, valued at approximately $5,900,751. The disclosure for this sale can be found here. Insiders have sold a total of 29,632 shares of company stock valued at $2,223,064 in the last 90 days. 4.70% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION WARNING: “Polar Capital LLP Has $41.42 Million Stake in Medidata Solutions Inc (MDSO)” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at www.tickerreport.com/banking-finance/4218887/polar-capital-llp-has-41-42-million-stake-in-medidata-solutions-inc-mdso.html.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Featured Article: Initial Public Offering (IPO)
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).